TEVA – Using Legitimate Distributor Payments to Conceal Bribes
On December 22, 2016, the Securities and Exchange Commission (SEC) announced that Teva Pharmaceutical Industries Limited had…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Eighth Aggregate Spend and Sunshine Act Conference
On June 15th and 16th, 2017, the Eighth Aggregate Spend and Sunshine Act Conference will be held at the Sonesta Philadelphia…
Dr. Stossel Corrects a Common Misconception
Thomas P. Stossel, MD, MD (Hon), is a visiting scholar at the American Enterprise Institute and professor emeritus at Harvard…
Going Back to the Roots of the False Claims Act – Baxter Settles cGMP…
While False Claims Act cases are relatively common in the life science industry, FCA cases for cGMP violations are not. This…
FDA Under Pressure to Speed Up Generic Approvals
As has been reported, the FDA is under pressure to speed up approval of generic medicines. In response, the FDA released data…
FDA Public Workshop on Opioid Training
The Food and Drug Administration (FDA) has announced a public workshop to obtain input on issues and challenges associated with…
New Documentary on Difficulties Faced by Patients With Chronic Pain
Dr. Lynn Webster of Utah recently produced a documentary about pain treatment. The documentary, “The Painful Truth,” can be found…
Project Exclusion: The OIG’s Latest Attempt to Make Its Exclusion Authority…
On January 11, 2017, the Office of Inspector General (OIG) at the U.S. Department of Health and Human Services (HHS), issued a new…
Will There Be an Uptick in FDA NDA Approvals This Year?
Late last year, John Jenkins, director of the FDA’s Office of New Drugs told attendees at an event that the decline in new drug…
Maryland Sends Bill to Governor on Drug Prices
The Maryland House recently passed a bill – House Bill 631 – with the goal of “prohibiting a manufacturer or wholesale distributor…